**Core Concept:** Pretreatment prophylaxis in patients with valvular disease is indicated to prevent potentially life-threatening complications like embolism during dental extractions. These complications occur due to the release of microorganisms, endotoxins, and emboli from the oral cavity into the bloodstream, which can reach the heart or cerebral vessels and cause severe consequences.

**Why the Correct Answer is Right:**

The correct answer is **D**: Heparin. Heparin is a widely used anticoagulant that inhibits the activation of factor X and prevents the formation of thrombin, thereby preventing platelet aggregation and blood clot formation. It is essential in patients with valvular disease, especially those with artificial heart valves, because it helps to reduce the risk of embolization during dental procedures.

**Why Each Wrong Option is Incorrect:**

A. **Option A: Aspirin (acetylsalicylic acid):** Although aspirin has antiplatelet properties, it lacks sufficient anticoagulant effect to provide sufficient protection in patients with valvular disease.

B. **Option B: Vitamin K antagonists (e.g., warfarin):** Vitamin K antagonists are not recommended for dental prophylaxis due to the risk of severe bleeding complications and the need for regular monitoring of the international normalized ratio (INR), which is not feasible before a dental procedure.

C. **Option C: Calcium channel blockers (e.g., amlodipine):** Calcium channel blockers are not effective in preventing embolization, and they do not provide adequate anticoagulation to counteract the risk of embolization in patients with valvular disease.

**Clinical Pearl:** The correct choice, Heparin, should be administered at least 6 hours before the dental procedure, and the patient should continue taking it for 24 hours after the dental procedure. This timeframe ensures adequate anticoagulation without increasing the risk of excessive bleeding during or after the procedure. Post-extraction bleeding risk generally lasts for 24 hours, while the anticoagulant effect of heparin lasts for only 6-8 hours. Therefore, the heparin administration should be tailored to cover the period of increased bleeding risk.